In our study, we found that UBE2T plays a key role in HCC development by promoting pyrimidine metabolism, and this process is dependent on UBE2T-mediated Akt K63-linked ubiquitination and Akt/β-catenin signaling pathway activation. The gene discussed is UBE2T; the disease is hepatocellular carcinoma.